erlotinib hydrochloride has been researched along with aminolevulinic acid in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (aminolevulinic acid) | Trials (aminolevulinic acid) | Recent Studies (post-2010) (aminolevulinic acid) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 6,475 | 665 | 2,740 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J; Yin, R; Yu, Y; Zou, Y | 1 |
1 other study(ies) available for erlotinib hydrochloride and aminolevulinic acid
| Article | Year |
|---|---|
5-aminolevulinic acid-mediated photodynamic therapy (ALA-PDT) for acneform rash induced by erlotinib: A case report.
Topics: Acne Vulgaris; Aminolevulinic Acid; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Erlotinib Hydrochloride; Exanthema; Humans; Lung Neoplasms; Photochemotherapy; Photosensitizing Agents; Skin Diseases | 2022 |